Plaque Psoriasis Comparator Research Study (1 Year)

Adults 18-75 years of age with stable chronic plaque-type psoriasis for at least 6 months, may qualify to participate.  Eligible participants must have plaque psoriasis covering 10% or more of their body, with moderate to severe disease at the time of study entry.

Eligible participants will receive investigational medication (active drug), an approved comparator medication, or placebo via injection.  Study medication and study-related care will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last about 1 year and include about 21 visits to the study centre.

Call the study centre near you or register now.

Learn more about
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more